Guide

How to use FeazAI.

A practical walkthrough of the FeazAI workflow — from a single search to a source-anchored weekly read. FeazAI helps you search public clinical trial registries, monitor sponsor activity, and use AI-assisted workflows to turn public signals into concise, source-aware intelligence. The app is built for professionals who follow clinical development, sponsor activity, and public biopharma signals without promotional framing.

At a glance: Search → Review → Dashboard → Favourite → Watchlist → Smart Match → Weekly Brief → Export.

1. Start with Explore

Explore is the entry point for searching public clinical trial registries. Search by disease, drug, sponsor, mechanism, trial keyword, indication, or therapy area, then refine with country, trial status, and trial phase filters. Open a trial to review study overview, recruitment status, phase, sponsor, locations, sites, investigators, and registry identifiers when available.

• Star important trials as favourites.
• Save useful searches so you can return to them later.

2. Review the Dashboard

After a search, FeazAI generates an analytical dashboard showing total trials, ongoing and planned trials, countries, sponsors, and landscape breakdowns. Tap any dashboard card to open a detailed audit view of the underlying public records.

3. Track sponsors with Watchlist

Watchlist lets you follow recent public activity from selected pharma and biotech sponsors. Filter by therapy area and time window. Therapy areas include Metabolic, Oncology, Infectious Disease, Immunology, Neurology, and Other.

Each sponsor opens into a public-signal intelligence summary: activity breakdown, score drivers, related news, and source-linked items. Tapping any item opens the original public source. Watchlist is framed as external public-signal monitoring, not an endorsement of any sponsor.

4. Use Signals as your monitoring area

Signals is the umbrella area in FeazAI for turning saved trials and Watchlist sponsors into ongoing monitoring workflows. It is the home for Smart Match, Watchlist, and the Weekly Brief.

5. Use Smart Match on favourite trials

Smart Match is an AI-assisted feature that helps surface related or potentially comparable trials around a favourite study.

From a favourited trial, open Signals → Smart Match → select the trial → run the analysis. The result helps you explore related trials, active sponsors, similar designs and populations, and other public trial activity worth reviewing.

Smart Match supports monitoring and review. It is not medical, regulatory, legal, commercial, or investment advice.

6. Read the Weekly Brief

The Weekly Brief is a premium AI-assisted feature that summarises recent public sponsor activity into a concise structured brief — helping you understand what changed, what was reported, what remains uncertain, and what may be worth monitoring next.

Sections in a brief may include:

• Summary
• Context
• Trial readouts
• What happened
• Watch next
• Evidence quality

Briefs are unlocked with credits, and an unlocked brief can be reopened later without paying again. Weekly Briefs support monitoring and review. They are not medical, regulatory, legal, investment, or promotional advice.

7. Export briefs for follow-up review

A Weekly Brief can be exported for sharing, saving, follow-up review, or additional source verification. Exported briefs work as a structured baseline you can carry into AI tools such as ChatGPT, Claude, or Gemini, or into internal review workflows.

Use an exported brief to:

• Check for newer public updates.
• Verify links and original sources.
• Separate confirmed information from uncertain items.
• Identify public sources to monitor next.

8. Suggested workflow

1. Search public registries in Explore.
2. Review the results list.
3. Open the Dashboard for a structured overview.
4. Favourite trials of interest.
5. Add sponsors to Watchlist.
6. Run Smart Match on a favourited trial.
7. Read the Weekly Brief for sponsor context.
8. Export a brief when you need to share or follow up.

9. Important note

FeazAI uses public sources only and is designed for public-source monitoring, analytical review, and workflow support. It is not medical advice, patient guidance, regulatory advice, legal advice, investment advice, or a substitute for reviewing primary sources. For any of those needs, consult an appropriately qualified professional.

Download FeazAI on the App Store →

Need help with something specific? Visit Support →